COURTNEY FREEMAN: Open Payments
NPI 1235778317 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 86 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $690 · 2025 $1,636
Food & beverage: $1,636
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $372 |
| Ardelyx, Inc. | 14 | $251 |
| ABBVIE INC. | 11 | $183 |
| Aimmune Therapeutics, Inc. | 7 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
| Madrigal Pharmaceuticals | 4 | $94 |
| PFIZER INC. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Novo Nordisk Inc | 2 | $46 |
Products named: TREMFYA, IBSRELA, ZENPEP, XIFAXAN, REZDIFFRA, CREON, VELSIPITY, DUPIXENT.
Industry payments across NC — which companies pay providers there.
